Answers are grounded in this paper and cite their sources.
Legionella longbeachae is a soil-associated cause of pneumonia that may escape routine diagnostic testing. Although this pathogen is well recognized in Australia and New Zealand, published case reports from China remain limited. We report severe community-acquired L. longbeachae pneumonia in a patient receiving long-term combined immunosuppressive therapy, with the diagnosis supported by metagenomic next-generation sequencing (mNGS) and clinical improvement observed during inpatient omadacycline therapy. A 68-year-old male orchard worker receiving long-term prednisone, methotrexate, and tofacitinib for rheumatoid arthritis presented with fever, cough, progressive dyspnea, hypoxemia, hyponatremia, and a marked inflammatory response after failing to respond to beta-lactam therapy. His occupational soil exposure, long-term immunosuppressive therapy, compatible clinical features, and poor response to beta-lactams raised suspicion of pneumonia caused by an atypical pathogen. mNGS of bronchoalveolar lavage fluid (BALF) detected L. longbeachae . Together, these findings supported the diagnosis of L. longbeachae pneumonia. However, because Legionella -specific culture and targeted molecular confirmation were not performed, the diagnosis was not independently confirmed by a species-specific assay. During hospitalization, he received intravenous omadacycline as the sole antimicrobial agent, together with non-invasive ventilation and supportive care. Symptoms, inflammatory markers, oxygenation, and chest computed tomography (CT) findings improved progressively before oral moxifloxacin was initiated after discharge. The patient was discharged after 12 days of omadacycline treatment and subsequently received a short course of oral moxifloxacin. We summarized 20 eligible cases diagnosed and treated in Asia, including ours. Most patients were older adults, many had soil-related exposure, and treatment commonly included macrolides, respiratory fluoroquinolones, rifampicin or tetracyclines. This case adds to the limited clinical experience with L. longbeachae pneumonia in Asia and suggests that omadacycline may represent an individualized treatment option. However, its efficacy against L. longbeachae remains unestablished, and it cannot currently replace standard first-line therapies.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: